The DISCOVER Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorDana-Farber Cancer Institute
About this trial
The purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer.
The name of the screening blood test being studied is:
-GRAIL Galleri MCED test
Eligibility criteria
Qualifiers
Be at least 22 years old
Have signs and symptoms suggestive of cancer and/or have imaging related to signs and symptoms of cancer being evaluated in the Cancer Diagnostic Service clinic
Disqualifiers
Individuals diagnosed with invasive malignancy within 3 years of enrollment
Individuals with active cancer requiring active therapeutic intervention at the time of participation (hormone therapy for breast/prostate cancer is considered acceptable and will not preclude participation)
Trial design
Treatments tested in this trial
- GRAIL Galleri MCED test
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov